[1]
|
Hahn, K.A., Wise, L.A., Riis, A.H., et al. (2013) Correlates of Menstrual Cycle Characteristics among Nulliparous Dan-ish Women. Clinical Epidemiology, 5, 311-319. https://doi.org/10.2147/CLEP.S46712
|
[2]
|
Lizneva, D., Suturina, L., Walker, W., et al. (2016) Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome. Fertility and Sterility, 106, 6-15. https://doi.org/10.1016/j.fertnstert.2016.05.003
|
[3]
|
Belenkaia, L.V., Lazareva, L.M., Walker, W., et al. (2019) Criteria, Phenotypes and Prevalence of Polycystic Ovary Syndrome. Minerva Ginecologica, 71, 211-223. https://doi.org/10.23736/S0026-4784.19.04404-6
|
[4]
|
Strowitzki, T., Capp, E. and Von Eye Corleta, H. (2010) The Degree of Cycle Irregularity Correlates with the Grade of Endocrine and Metabolic Disorders in PCOS Patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 149, 178-181. https://doi.org/10.1016/j.ejogrb.2009.12.024
|
[5]
|
Meier, R.K. (2018) Polycystic Ovary Syndrome. The Nursing Clinics of North America, 53, 407-420.
https://doi.org/10.1016/j.cnur.2018.04.008
|
[6]
|
Balen, A.H., Conway, G.S., Kaltsas, G., et al. (1995) Polycystic Ovary Syndrome: The Spectrum of the Disorder in 1741 Patients. Human Reproduction (Oxford, England), 10, 2107-2111.
https://doi.org/10.1093/oxfordjournals.humrep.a136243
|
[7]
|
Yu, T., Wu, D., Cao, Y., et al. (2021) Association between Menstrual Patterns and Adverse Pregnancy Outcomes in Patients with Polycystic Ovary Syndrome. Frontiers in Endocrinology (Lausanne), 12, Article ID: 740377.
https://doi.org/10.3389/fendo.2021.740377
|
[8]
|
Shi, Y., Guo, M., Yan, J., et al. (2007) Analysis of Clinical Char-acteristics in Large-Scale Chinese Women with Polycystic Ovary Syndrome. Neuro Enocrinology Letters, 28, 807-810.
|
[9]
|
Anjum, S., Askari, S., Riaz, M., et al. (2020) Clinical Presentation and Frequency of Metabolic Syndrome in Women with Polycystic Ovary Syndrome: An Experience from a Tertiary Care Hospital in Pakistan. Cureus, 12, e11860.
https://doi.org/10.7759/cureus.11860
|
[10]
|
Gorry, A., White, D.M. and Franks, S. (2006) Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment. Endocrine, 30, 27-33. https://doi.org/10.1385/ENDO:30:1:27
|
[11]
|
Oberg, E., Gidlöf, S., Jakson, I., et al. (2019) Improved Menstrual Function in Obese Women with Polycystic Ovary Syndrome after Behavioural Modification Intervention—A Random-ized Controlled Trial. Clinical Endocrinology (Oxford), 90, 468-478. https://doi.org/10.1111/cen.13919
|
[12]
|
Fraison,, E., Kostova, E., Moran, L.J., et al. (2020) Metformin versus the Combined Oral Contraceptive Pill for Hirsutism, Acne, and Menstrual Pattern in Polycystic Ovary Syndrome. The Cochrane Database of Systematic Reviews, 8, Cd005552. https://doi.org/10.1002/14651858.CD005552.pub3
|
[13]
|
Medenica, S., Nedeljkovic, O., Radojevic, N., et al. (2015) Thyroid Dysfunction and Thyroid Autoimmunity in Euthyroid Women in Achieving Fertility. European Review for Medical and Pharmacological Sciences, 19, 977-987.
|
[14]
|
Dittrich, R., Beckmann, M.W., Oppelt, P.G., et al. (2011) Thyroid Hormone Receptors and Reproduction. Journal of Reproductive Immunology, 90, 58-66. https://doi.org/10.1016/j.jri.2011.02.009
|
[15]
|
Kakuno, Y., Amino, N., Kanoh, M., et al. (2010) Menstrual Dis-turbances in Various Thyroid Diseases. Endocrine Journal, 57, 1017-1022. https://doi.org/10.1507/endocrj.K10E-216
|
[16]
|
Sun, H., Saeedi, P., Karuranga, S., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Re-search and Clinical Practice, 183, 109-119.
https://doi.org/10.1016/j.diabres.2021.109119
|
[17]
|
Schroeder, B., Hertweck, S.P., Sanfilippo, J.S., et al. (2000) Correlation between Glycemic Control and Menstruation in Diabetic Adolescents. The Journal of Reproductive Medicine, 45, 1-5.
|
[18]
|
Gaete, X., Vivanco, M., Eyzaguirre, F.C., et al. (2010) Menstrual Cycle Irregularities and Their Relation-ship with HbA1c and Insulin Dose in Adolescents with Type 1 Diabetes Mellitus. Fertility and Sterility, 94, 1822-1826.
https://doi.org/10.1016/j.fertnstert.2009.08.039
|
[19]
|
Kelsey, M.M., Braffett, B.H., Geffner, M.E., et al. (2018) Menstrual Dysfunction in Girls from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. The Journal of Clinical Endocrinology and Metabolism, 103, 2309-2318. https://doi.org/10.1210/jc.2018-00132
|
[20]
|
Rieder, J., Santoro, N., Cohen, H.W., et al. (2008) Body Shape and Size and Insulin Resistance as Early Clinical Predictors of Hyperandrogenic Anovulation in Ethnic Minority Adolescent Girls. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 43, 115-124. https://doi.org/10.1016/j.jadohealth.2008.02.003
|
[21]
|
Rosenfield, R.L. and Bordini, B. (2010) Evidence That Obe-sity and Androgens Have Independent and Opposing Effects on Gonadotropin Production from Puberty to Maturity. Brain Research, 1364, 186-197.
https://doi.org/10.1016/j.brainres.2010.08.088
|
[22]
|
Chanson, P. and Maiter, D. (2019) The Epidemiology, Diagno-sis and Treatment of Prolactinomas: The Old and the New. Best Practice & Research Clinical Endocrinology & Metabo-lism, 33, Article ID: 101290.
https://doi.org/10.1016/j.beem.2019.101290
|
[23]
|
Lee, D.Y., Oh, Y.K., Yoon, B.K., et al. (2012) Prevalence of Hyperprolactinemia in Adolescents and Young Women with Menstruation-Related Problems. American Journal of Ob-stetrics and Gynecology, 206, 213.e1-5.
https://doi.org/10.1016/j.ajog.2011.12.010
|
[24]
|
Bernard, V., Young, J. and Binart, N. (2019) Prolactin—A Plei-otropic Factor in Health and Disease. Nature Reviews Endocrinology, 15, 356-365. https://doi.org/10.1038/s41574-019-0194-6
|
[25]
|
Wang, A.T., Mullan, R.J., Lane, M.A., et al. (2012) Treatment of Hyperprolactinemia: A Systematic Review and Meta-Analysis. Systematic Reviews, 1, 33. https://doi.org/10.1186/2046-4053-1-33
|
[26]
|
Lamba, N., Noormohamed, N., Simjian, T., et al. (2019) Fertility after Transsphenoidal Surgery in Patients with Prolactinomas: A Meta-Analysis. Clinical Neurology and Neurosurgery, 176, 53-60.
https://doi.org/10.1016/j.clineuro.2018.11.024
|
[27]
|
Ragnarsson, O., Olsson, D.S., Chantzichristos, D., et al. (2019) The Incidence of Cushing’s Disease: A Nationwide Swedish Study. Pituitary, 22, 179-186. https://doi.org/10.1007/s11102-019-00951-1
|
[28]
|
Lado-Abeal, J., Rodriguez-Arnao, J., Newell-Price, J.D., et al. (1998) Menstrual Abnormalities in Women with Cushing’s Disease Are Correlated with Hypercortisolemia Rather than Raised Circulating Androgen Levels. The Journal of Clinical Endocrinology and Metabolism, 83, 3083-3088. https://doi.org/10.1210/jc.83.9.3083
|
[29]
|
Valassi, E. (2022) Clinical Presentation and Etiology of Cushing’s Syn-drome: Data from ERCUSYN. Journal of Neuroendocrinology, 34, e13114. https://doi.org/10.1111/jne.13114
|
[30]
|
Espinosa-de-Los-Monteros, A.L., Sosa, E., Martinez, N., et al. (2013) Per-sistence of Cushing’s Disease Symptoms and Comorbidities after Surgical Cure: A Long-Term, Integral Evaluation. En-docrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 19, 252-258.
https://doi.org/10.4158/EP12247.OR
|
[31]
|
Lavrentaki, A., Paluzzi, A., Wass, J.A., et al. (2017) Epidemiology of Acromegaly: Review of Population Studies. Pituitary, 20, 4-9. https://doi.org/10.1007/s11102-016-0754-x
|
[32]
|
Livadas, S. and Bothou, C. (2019) Management of the Female with Non-Classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach. Frontiers in Endocrinol-ogy (Lausanne), 10, 366.
https://doi.org/10.3389/fendo.2019.00366
|
[33]
|
Yeliosof, O. and Gangat, M. (2019) Diagnosis and Management of Hypopituitarism. Current Opinion in Pediatrics, 31, 531-536. https://doi.org/10.1097/MOP.0000000000000779
|